- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 11 Reference Ions Near m/z 476.9868
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000063357 Unreliable | 476.9856 | 476.9856 ~ 476.9856 MzDiff: none |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
0.13 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000060286 Unreliable | 476.9866 | 476.9863 ~ 476.9868 MzDiff: 2.3 ppm |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
0.54 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
MSI_000061218 Unreliable | 476.9868 | 476.9868 ~ 476.9868 MzDiff: 0.1 ppm |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
1.63 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000063465 Unreliable | 476.9856 | 476.9856 ~ 476.9856 MzDiff: 0.1 ppm |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
0.11 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
MSI_000002823 Unavailable | 476.989 | 476.989 ~ 476.989 MzDiff: none |
(2z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]propanimidic acid (BioDeep_00002249514) Formula: C14H15Br2N5O3 (458.9542) |
-0.45 (100%) | Rattus norvegicus [UBERON:0001950] neocortex |
MSI_000003404 Unavailable | 476.989 | 476.989 ~ 476.989 MzDiff: none |
(2z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]propanimidic acid (BioDeep_00002249514) Formula: C14H15Br2N5O3 (458.9542) |
-0.39 (100%) | Rattus norvegicus [UBERON:0002037] cerebellum |
MSI_000005102 Unavailable | 476.989 | 476.989 ~ 476.989 MzDiff: none |
(2z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]propanimidic acid (BioDeep_00002249514) Formula: C14H15Br2N5O3 (458.9542) |
-0.52 (100%) | Rattus norvegicus [UBERON:0002298] brainstem |
MSI_000005729 Unavailable | 476.989 | 476.989 ~ 476.989 MzDiff: none |
(2z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]propanimidic acid (BioDeep_00002249514) Formula: C14H15Br2N5O3 (458.9542) |
-0.53 (100%) | Rattus norvegicus [UBERON:0002435] striatum |
MSI_000025217 Unreliable | 476.987 | 476.987 ~ 476.987 MzDiff: none |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
1.69 (100%) | Mus musculus [UBERON:0004269] upper arm connective tissue |
MSI_000059294 Unreliable | 476.9856 | 476.9856 ~ 476.9856 MzDiff: none |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
2.09 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000059714 Unreliable | 476.9863 | 476.9863 ~ 476.9863 MzDiff: none |
Ebrotidine (BioDeep_00000036542) Formula: C14H17BrN6O2S3 (475.9758) |
0.32 (100%) | Mus musculus [UBERON:0002298] brainstem |
Found 13 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
(2z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]propanimidic acid Formula: C14H15Br2N5O3 (458.9542) Adducts: [M+NH4]+ (Ppm: 2.1) |
Rattus norvegicus (Brain) |
Spectroswiss - sol_2x_br_2Resolution: 17μm, 488x193
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 8.1) |
Mus musculus (Left upper arm) |
357_l_total ion countResolution: 50μm, 97x131
Diseased |
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 4.1) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 4.4) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 5.4) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
4-Acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid Formula: C17H14N2O7S3 (453.9963) Adducts: [M+Na]+ (Ppm: 8.1) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
m/z_476.9891 Formula: - (n/a) Adducts: (Ppm: 0) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 6.7) |
Mus musculus (brain) |
Brain01_Bregma-3-88b_centroidResolution: 17μm, 265x320
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 7.7) |
Mus musculus (brain) |
Brain01_Bregma1-42_02_centroidResolution: 17μm, 434x258
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 7.7) |
Mus musculus (brain) |
Brain01_Bregma1-42_01_centroidResolution: 17μm, 447x118
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 5.2) |
Mus musculus (brain) |
Brain02_Bregma1-42_03Resolution: 17μm, 483x403
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 5) |
Mus musculus (brain) |
Brain02_Bregma-3-88Resolution: 17μm, 288x282
|
|
Ebrotidine Formula: C14H17BrN6O2S3 (475.9758) Adducts: [M+H]+ (Ppm: 5.2) |
Mus musculus (brain) |
Brain02_Bregma-1-46Resolution: 17μm, 294x399
|
|